Nifty

:

22419.95

Sensex

:

73730.16

-150.40 (-0.67%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22419.95
73730.16

-150.40 (-0.67%)
-609.28 (-0.82%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

55/99

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

521.55

26-Apr-2024

Open
High
Low
Previous Close

532.00
534.45
518.00
531.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

112747
589.96
566.95
320.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,730.68
24.32
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,909.97
0.38%
2.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 373.03 359.33 3.81% 356.14 404.50 -11.96% 358.14 373.15 -4.02% 374.27 364.70 2.62%
Expenses 284.75 286.77 -0.70% 282.34 324.24 -12.92% 281.40 294.44 -4.43% 297.47 296.49 0.33%
EBITDA 88.28 72.56 21.66% 73.80 80.26 -8.05% 76.74 78.71 -2.50% 76.80 68.21 12.59%
EBIDTM 23.67% 20.19% 20.72% 19.84% 21.43% 21.09% 20.52% 18.70%
Other Income 0.20 0.04 400.00% 0.00 1.24 -100.00% 4.86 0.00 0 0.00 2.51 -100.00%
Interest 4.10 5.12 -19.92% 3.82 5.52 -30.80% 4.03 4.05 -0.49% 5.80 4.40 31.82%
Depreciation 16.94 14.56 16.35% 16.32 14.55 12.16% 15.44 12.41 24.42% 14.25 12.44 14.55%
PBT 67.44 52.92 27.44% 53.66 61.43 -12.65% 62.13 62.25 -0.19% 56.75 53.88 5.33%
Tax 19.25 14.38 33.87% 11.85 15.50 -23.55% 14.50 15.00 -3.33% 16.75 9.00 86.11%
PAT 48.19 38.54 25.04% 41.81 45.93 -8.97% 47.63 47.25 0.80% 40.00 44.88 -10.87%
PATM 12.92% 10.73% 11.74% 11.35% 13.30% 12.66% 10.69% 12.31%
EPS 5.32 4.25 25.18% 4.61 5.07 -9.07% 5.26 5.22 0.77% 4.42 4.95 -10.71%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 448.69 471.62 -4.86% 439.80 531.17 -17.20% 458.36 457.37 0.22% 485.06 460.30 5.38%
Expenses 353.01 385.38 -8.40% 351.81 441.40 -20.30% 373.49 371.32 0.58% 405.07 384.68 5.30%
EBITDA 95.68 86.24 10.95% 87.99 89.77 -1.98% 84.87 86.05 -1.37% 79.99 75.62 5.78%
EBIDTM 21.32% 18.29% 20.01% 16.90% 18.52% 18.81% 16.49% 16.43%
Other Income 1.39 0.29 379.31% 0.98 1.28 -23.44% 0.48 0.02 2,300.00% 0.74 2.52 -70.63%
Interest 4.48 5.25 -14.67% 3.89 5.63 -30.91% 4.17 4.24 -1.65% 5.94 4.59 29.41%
Depreciation 18.77 16.25 15.51% 18.14 16.57 9.47% 17.20 13.77 24.91% 15.95 14.07 13.36%
PBT 73.82 65.03 13.52% 66.94 68.85 -2.77% 63.98 68.06 -5.99% 58.84 59.48 -1.08%
Tax 21.06 17.34 21.45% 15.14 17.76 -14.75% 16.89 16.22 4.13% 15.97 10.61 50.52%
PAT 52.76 47.69 10.63% 51.80 51.09 1.39% 47.09 51.84 -9.16% 42.87 48.87 -12.28%
PATM 11.76% 10.11% 11.78% 9.62% 10.27% 11.33% 8.84% 10.62%
EPS 5.82 5.26 10.65% 5.72 5.64 1.42% 5.20 5.72 -9.09% 4.73 5.36 -11.75%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22
Net Sales 1,461.58 1,511.25 941.02 Net Sales Growth -2.67% 60.60% Cost Of Goods Sold 766.34 700.53 451.66 Gross Profit 695.24 810.72 489.36 GP Margin 47.57% 53.65% 52.00% Total Expenditure 1,145.96 1,202.91 761.24 Power & Fuel Cost - 132.98 69.73 % Of Sales - 8.80% 7.41% Employee Cost - 122.16 79.98 % Of Sales - 8.08% 8.50% Manufacturing Exp. - 200.30 132.62 % Of Sales - 13.25% 14.09% General & Admin Exp. - 14.82 6.98 % Of Sales - 0.98% 0.74% Selling & Distn. Exp. - 31.02 20.25 % Of Sales - 2.05% 2.15% Miscellaneous Exp. - 1.10 0.01 % Of Sales - 0.07% 0.00% EBITDA 315.62 308.34 179.78 EBITDA Margin 21.59% 20.40% 19.10% Other Income 5.06 1.28 2.51 Interest 17.75 20.49 11.34 Depreciation 62.95 55.77 37.23 PBT 239.98 233.36 133.73 Tax 62.35 61.63 27.00 Tax Rate 25.98% 26.41% 20.19% PAT 177.63 171.73 106.73 PAT before Minority Interest 177.63 171.73 106.73 Minority Interest 0.00 0.00 0.00 PAT Margin 12.15% 11.36% 11.34% PAT Growth 0.58% 60.90% EPS 19.61 18.95 11.78

Description TTM Mar 23 Mar 22
Net Sales 1,831.91 1,945.23 1,199.94 Net Sales Growth -4.61% 62.11% Cost Of Goods Sold 1,062.60 1,015.81 637.67 Gross Profit 769.31 929.43 562.27 GP Margin 41.99% 47.78% 46.86% Total Expenditure 1,483.38 1,603.18 994.67 Power & Fuel Cost - 165.27 90.00 % Of Sales - 8.50% 7.50% Employee Cost - 129.69 85.20 % Of Sales - 6.67% 7.10% Manufacturing Exp. - 215.81 145.95 % Of Sales - 11.09% 12.16% General & Admin Exp. - 16.64 8.13 % Of Sales - 0.86% 0.68% Selling & Distn. Exp. - 58.45 27.38 % Of Sales - 3.00% 2.28% Miscellaneous Exp. - 1.52 0.34 % Of Sales - 0.08% 0.03% EBITDA 348.53 342.05 205.27 EBITDA Margin 19.03% 17.58% 17.11% Other Income 3.59 2.32 4.19 Interest 18.48 21.05 11.96 Depreciation 70.06 62.54 42.12 PBT 263.58 260.77 155.38 Tax 69.06 67.28 33.13 Tax Rate 26.20% 25.80% 21.32% PAT 194.52 193.49 122.25 PAT before Minority Interest 194.52 193.49 122.25 Minority Interest 0.00 0.00 0.00 PAT Margin 10.62% 9.95% 10.19% PAT Growth -2.49% 58.27% EPS 21.47 21.36 13.49

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22
Shareholder's Funds 1,438.58 1,284.28 Share Capital 45.31 0.25 Total Reserves 1,393.27 1,238.71 Non-Current Liabilities 69.38 60.88 Secured Loans 0.00 0.00 Unsecured Loans 0.00 0.00 Long Term Provisions 0.00 0.00 Current Liabilities 455.31 481.67 Trade Payables 219.75 131.61 Other Current Liabilities 14.74 8.98 Short Term Borrowings 206.71 324.62 Short Term Provisions 14.11 16.46 Total Liabilities 1,963.27 1,826.83 Net Block 848.40 701.12 Gross Block 1,303.76 1,100.71 Accumulated Depreciation 455.37 399.59 Non Current Assets 1,004.30 936.56 Capital Work in Progress 101.90 187.37 Non Current Investment 42.67 39.87 Long Term Loans & Adv. 11.33 8.21 Other Non Current Assets 0.00 0.00 Current Assets 958.98 890.27 Current Investments 0.00 0.00 Inventories 537.68 444.38 Sundry Debtors 361.61 304.22 Cash & Bank 13.18 56.50 Other Current Assets 46.50 11.53 Short Term Loans & Adv. 38.31 73.65 Net Current Assets 503.66 408.60 Total Assets 1,963.28 1,826.83

Description Mar 23 Mar 22
Shareholder's Funds 1,558.49 1,386.48 Share Capital 45.31 0.25 Total Reserves 1,513.17 1,340.91 Non-Current Liabilities 80.87 72.76 Secured Loans 0.18 0.55 Unsecured Loans 0.00 0.00 Long Term Provisions 1.32 0.00 Current Liabilities 591.57 580.67 Trade Payables 346.76 214.59 Other Current Liabilities 16.92 11.89 Short Term Borrowings 213.78 337.73 Short Term Provisions 14.11 16.46 Total Liabilities 2,230.93 2,039.91 Net Block 925.84 782.09 Gross Block 1,431.25 1,225.00 Accumulated Depreciation 505.41 442.90 Non Current Assets 1,075.17 1,011.75 Capital Work in Progress 101.87 187.37 Non Current Investment 35.52 32.23 Long Term Loans & Adv. 11.93 10.07 Other Non Current Assets 0.00 0.00 Current Assets 1,155.76 1,028.15 Current Investments 38.18 0.00 Inventories 602.04 475.45 Sundry Debtors 440.05 376.66 Cash & Bank 25.00 83.27 Other Current Assets 50.49 10.74 Short Term Loans & Adv. 42.91 82.03 Net Current Assets 564.19 447.48 Total Assets 2,230.93 2,039.90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22
Cash From Operating Activity 228.69 -64.84 PBT 233.36 133.73 Adjustment 75.37 46.08 Changes in Working Capital -23.30 -229.65 Cash after chg. in Working capital 285.42 -49.84 Interest Paid 0.00 0.00 Tax Paid -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -115.55 -133.54 Net Fixed Assets -117.58 Net Investments -2.80 Others 4.83 Cash from Financing Activity -156.53 254.63 Net Cash Inflow / Outflow -43.39 56.25 Opening Cash & Equivalents 56.50 0.25 Closing Cash & Equivalent 13.11 56.50

Description Mar 23 Mar 22
Cash From Operating Activity 263.00 -43.70 PBT 260.77 155.38 Adjustment 81.82 52.41 Changes in Working Capital -17.22 -230.36 Cash after chg. in Working capital 325.38 -22.57 Interest Paid 0.00 0.00 Tax Paid -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -157.80 -138.74 Net Fixed Assets -117.58 Net Investments -2.80 Others -37.42 Cash from Financing Activity -163.46 260.38 Net Cash Inflow / Outflow -58.27 77.94 Opening Cash & Equivalents 83.27 5.33 Closing Cash & Equivalent 25.00 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22
Book Value (Rs.) 158.74 49558.52 ROA 9.06% 11.68% ROE 12.83% 17.23% ROCE 15.60% 18.03% Fixed Asset Turnover 1.26 0.85 Receivable days 80.41 118.00 Inventory Days 118.59 172.36 Payable days 91.54 53.18 Cash Conversion Cycle 107.46 237.18 Total Debt/Equity 0.14 0.26 Interest Cover 12.39 12.79

Description Mar 23 Mar 22
Book Value (Rs.) 171.97 53646.60 ROA 9.06% 11.98% ROE 13.35% 18.23% ROCE 16.11% 19.40% Fixed Asset Turnover 1.46 0.98 Receivable days 76.62 114.57 Inventory Days 101.09 144.62 Payable days 100.85 61.41 Cash Conversion Cycle 76.86 197.78 Total Debt/Equity 0.14 0.25 Interest Cover 13.39 13.99

Top Investors:

life insurance corporation of india

ntasain discovery master fund

nishant pradip shah

morgan stanley investment funds emerging leaders equity fund

aditya birla sun life trustee private limited a/c aditya birla sun life flexi cap fund

baron emerging markets fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs - Quarterly Results
7th Feb 2024, 16:42 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback